BlossomHill Therapeutics, Inc. — Form D
BlossomHill Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-11. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-01-11
- Form: D
- Accession: 0001839970-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Investors: 3
- Date of first sale: 2020-12-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-385888
Issuer
- Name: BlossomHill Therapeutics, Inc.
- CIK: 0001839970
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 10255 SCIENCE CENTER DRIVE, SAN DIEGO, CA, 92121
- Phone: 858-732-3880
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| GEORGE LEE | Director | New York, NY |
| CARL GORDON | Director | SAN DIEGO, CA |
| YISHAN LI | Director | SAN DIEGO, CA |
| YISHAN LI | Executive Officer | SAN DIEGO, CA |
| SUNDEEP AGRAWAL | Director | SAN DIEGO, CA |
| BIHUA CHEN | Director | Boston, MA |
| TIMOTHY STUBBS | Director | SAN DIEGO, CA |
| JINGRONG JEAN CUI | Director | SAN DIEGO, CA |
| JINGRONG JEAN CUI | Executive Officer | SAN DIEGO, CA |
| Hongbo Lu | Director | San Diego, CA |
| George Peter Lee | Director | San Diego, CA |
| Li Peter Yishan | Director | San Diego, CA |
| Li Peter Yishan | Executive Officer | San Diego, CA |
| Bihua Peter Chen | Director | San Diego, CA |
| Carl Peter Gordon | Director | San Diego, CA |
| Jingrong Peter Jean Cui | Director | San Diego, CA |
| Jingrong Peter Jean Cui | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More